ATOS · Atossa Therapeutics, Inc.
$2.60
+0.04 (+1.56%)
At close · Aug 14
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not yet established an ongoing source of revenue sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. ... Although the Company received this infusion of capital, management maintains that in order to alleviate the conditions that raise substantial doubt, the Company will need, among other things, additional capital resources. ... However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.”View the 10-Q filed Aug 7, 2026
Market Cap
$25.95M
Shares
9.98M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
749,683
-1.4% vs reported
Short Squeeze Score
68/100
Short interest 7.6% of shares — P84
Days to cover 13.5 — P93
Price vs VWAP +4.4% — P65
Short-volume trend -18.2% — P7
Short interest change -2.1% — P47
Worst FTD 0.43% of shares — P90
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 760,127 | 776,246 | -16,119 | 13.48 |
| 2026-07-15 | 776,246 | 704,017 | +72,229 | 4.66 |
| 2026-06-30 | 704,017 | 533,343 | +170,674 | 2.20 |
| 2026-06-15 | 533,343 | 400,996 | +132,347 | 2.03 |
| 2026-05-29 | 400,996 | 341,344 | +59,652 | 9.57 |
| 2026-05-15 | 341,344 | 337,509 | +3,835 | 5.59 |
| 2026-04-30 | 337,509 | 351,934 | -14,425 | 6.80 |
| 2026-04-15 | 351,934 | 327,683 | +24,251 | 5.64 |
| 2026-03-31 | 327,683 | 320,202 | +7,481 | 4.52 |
| 2026-03-13 | 320,202 | 361,039 | -40,837 | 3.25 |
| 2026-02-27 | 361,039 | 408,724 | -47,685 | 4.86 |
| 2026-02-13 | 408,724 | 4,696,759 | -4,288,035 | 1.31 |
| 2026-01-30 | 313,117 | 241,402 | +71,716 | 1.57 |
| 2026-01-15 | 241,402 | 154,331 | +87,071 | 3.05 |
| 2025-12-31 | 154,331 | 152,270 | +2,061 | 1.87 |
| 2025-12-15 | 152,270 | 103,604 | +48,666 | 1.56 |
| 2025-11-28 | 103,604 | 91,941 | +11,663 | 3.07 |
| 2025-11-14 | 91,941 | 88,033 | +3,908 | 2.61 |
| 2025-10-31 | 88,033 | 91,360 | -3,327 | 1.82 |
| 2025-10-15 | 91,360 | 156,391 | -65,031 | 1.00 |
| 2025-09-30 | 156,391 | 186,665 | -30,274 | 3.84 |
| 2025-09-15 | 186,665 | 238,141 | -51,477 | 5.42 |
| 2025-08-29 | 238,141 | 243,987 | -5,845 | 7.98 |
Showing 1–23 of 23 settlements
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
34 filings
34 filers
Visit website
Investor relations